D. Natuzzi et al., Inactivation of the reconstituted oxoglutarate carrier from bovine heart mitochondria by pyridoxal 5 '-phosphate, J BIOENER B, 31(6), 1999, pp. 535-541
The effect of pyridoxal 5'-phosphate and some other lysine reagents on the
purified, reconstituted mitochondrial oxoglutarate transport protein has be
en investigated. The inhibition of oxoglutarate/oxoglutarate exchange by py
ridoxal 5'-phosphate can be reversed by passing the proteoliposomes through
a Sephadex column but the reduction of the Schiff's base by sodium borohyd
ride yielded an irreversible inactivation of the oxoglutarate carrier prote
in. Pyridoxal 5'-phosphate, which caused a time- and concentration-dependen
t inactivation of oxoglutarate transport with an IC50 Of 0.5 mM, competed w
ith the substrate for binding to the oxoglutarate carrier (K-i = 0.4 mM). K
inetic analysis of oxoglutarate transport inhibition by pyridoxal 5'-phosph
ate indicated that modification of a single amino acid residue/carrier mole
cule was sufficient for complete inhibition of oxoglutarate transport. Afte
r reduction with sodium borohydride [H-3]pyridoxal 5'-phosphate bound coval
ently to the oxoglutarate carrier. Incubation of the proteoliposomes with o
xoglutarate or L-malate protected the carrier against inactivation and no r
adioactivity was found associated with the carrier protein. In contrast, gl
utarate and substrates of other mitochondrial carrier proteins were unable
to protect the carrier. Mersalyl, which is a known sulfhydryl reagent, also
failed to protect the oxoglutarate carrier against inhibition by pyridoxal
5'-phosphate. These results indicate that pyridoxal 5'-phosphate interacts
with the oxoglutarate carrier at a site(s) (i.e., a lysine residue(s) and/
or the amino-terminal glycine residue) which is essential for substrate tra
nslocation and may be localized at or near the substrate-binding site.